|
response to genistein
|
GO:0033595 |
1 |
0.994
|
|
|
protein folding
|
GO:0006457 |
38 |
0.875
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.817
|
|
|
protein refolding
|
GO:0042026 |
14 |
0.815
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.801
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.736
|
|
|
chaperone mediated protein folding
|
GO:0061077 |
13 |
0.719
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.692
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.682
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.674
|
Fly |
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.658
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.651
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.640
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.621
|
|
|
defense response
|
GO:0006952 |
315 |
0.596
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.585
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.580
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.537
|
|
|
de novo protein folding
|
GO:0006458 |
2 |
0.521
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.488
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.467
|
Rat |
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.428
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.428
|
Rat |
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.416
|
|
|
behavioral fear response
|
GO:0001662 |
0 |
0.416
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.411
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.410
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.405
|
|
|
chaperone cofactor dependent protein refolding
|
GO:0070389 |
4 |
0.403
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.401
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.386
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.385
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.375
|
|
|
heat acclimation
|
GO:0010286 |
3 |
0.363
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.363
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.360
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.360
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.328
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.326
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.317
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.316
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.312
|
|
|
fear response
|
GO:0042596 |
0 |
0.297
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.283
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.283
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.278
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.275
|
|
|
response to activity
|
GO:0014823 |
0 |
0.275
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.258
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.258
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.242
|
|
|
response to phenylpropanoid
|
GO:0080184 |
1 |
0.236
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.232
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.228
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.227
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.226
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.222
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.216
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.210
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.208
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.207
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.206
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.203
|
|
|
response to hydroxyisoflavone
|
GO:0033594 |
1 |
0.203
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.203
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.201
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.201
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.197
|
|
|
associative learning
|
GO:0008306 |
1 |
0.197
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.196
|
|
|
response to drug
|
GO:0042493 |
81 |
0.194
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.191
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.187
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.185
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.181
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.179
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.177
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.174
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.173
|
Rat |
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.171
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.170
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.169
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.167
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.166
|
|
|
circadian sleep wake cycle
|
GO:0042745 |
2 |
0.165
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.163
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.159
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.158
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.156
|
|
|
cation transport
|
GO:0006812 |
331 |
0.154
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.153
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.152
|
|
|
positive regulation of oxidoreductase activity
|
GO:0051353 |
26 |
0.152
|
|
|
cell development
|
GO:0048468 |
328 |
0.151
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.148
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.148
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.146
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.146
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.146
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.145
|
Rat |
|
negative regulation of fibril organization
|
GO:1902904 |
1 |
0.145
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.145
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.145
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.142
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.142
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.141
|
|
|
system process
|
GO:0003008 |
349 |
0.139
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.136
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.132
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.132
|
|
|
cellular response to heat
|
GO:0034605 |
14 |
0.129
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.128
|
|
|
cellular heat acclimation
|
GO:0070370 |
3 |
0.122
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.121
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.121
|
|
|
neuron death
|
GO:0070997 |
65 |
0.121
|
Rat |
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.120
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.119
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.118
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.118
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.118
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.115
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.115
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.115
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.114
|
|
|
cell growth
|
GO:0016049 |
160 |
0.114
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.113
|
|
|
hypothalamus development
|
GO:0021854 |
1 |
0.113
|
|
|
chaperone mediated protein folding requiring cofactor
|
GO:0051085 |
1 |
0.110
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.109
|
Yeast Mouse Rat |
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.109
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.108
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.108
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.107
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.106
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.105
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.105
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.105
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.104
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.101
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.099
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.099
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.097
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.097
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.097
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.097
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.096
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.096
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.095
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.095
|
|
|
establishment of protein localization to mitochondrion
|
GO:0072655 |
22 |
0.095
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.094
|
|
|
rna processing
|
GO:0006396 |
255 |
0.093
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.093
|
Rat |
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.092
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.092
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.091
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.091
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.091
|
Rat |
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.091
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.090
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.089
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.089
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.089
|
|
|
translation
|
GO:0006412 |
132 |
0.088
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.087
|
|
|
segmentation
|
GO:0035282 |
4 |
0.087
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.087
|
|
|
activation of jnkk activity
|
GO:0007256 |
1 |
0.087
|
|
|
dna repair
|
GO:0006281 |
198 |
0.087
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.086
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.085
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.085
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.084
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.084
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.083
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.082
|
|
|
small nucleolar ribonucleoprotein complex assembly
|
GO:0000491 |
3 |
0.082
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
2 |
0.079
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.078
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.078
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
61 |
0.078
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.077
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.076
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.076
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.076
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.076
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.075
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.075
|
|
|
steroid hormone mediated signaling pathway
|
GO:0043401 |
12 |
0.075
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.074
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.074
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.074
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.074
|
|
|
lactation
|
GO:0007595 |
3 |
0.074
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.073
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.073
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.073
|
Rat |
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.072
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.072
|
|
|
immune system development
|
GO:0002520 |
195 |
0.072
|
|
|
rna interference
|
GO:0016246 |
4 |
0.072
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.071
|
|
|
gland development
|
GO:0048732 |
48 |
0.071
|
|
|
detection of visible light
|
GO:0009584 |
11 |
0.071
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
25 |
0.071
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.070
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.070
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.070
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.070
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.069
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.069
|
|
|
srp dependent cotranslational protein targeting to membrane
|
GO:0006614 |
2 |
0.068
|
|
|
regulation of atpase activity
|
GO:0043462 |
25 |
0.068
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.068
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.068
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.068
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.067
|
|
|
embryo development
|
GO:0009790 |
123 |
0.067
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.067
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.066
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.066
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.066
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.066
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.065
|
|
|
protein localization to mitochondrion
|
GO:0070585 |
25 |
0.065
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.064
|
|
|
peptidyl threonine modification
|
GO:0018210 |
45 |
0.064
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.064
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.063
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.063
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.061
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.061
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.060
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
27 |
0.059
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.058
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.058
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.058
|
Mouse |
|
reproductive structure development
|
GO:0048608 |
55 |
0.058
|
|
|
regeneration
|
GO:0031099 |
4 |
0.057
|
|
|
serine phosphorylation of stat protein
|
GO:0042501 |
4 |
0.057
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.057
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.057
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.057
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
19 |
0.056
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.056
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
7 |
0.056
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.055
|
|
|
response to unfolded protein
|
GO:0006986 |
24 |
0.055
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.055
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.055
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.054
|
Rat |
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.054
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.054
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.053
|
|
|
regulation of nitric oxide synthase activity
|
GO:0050999 |
11 |
0.053
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.053
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
25 |
0.052
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.052
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.052
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.052
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.051
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.051
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.051
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.051
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.050
|
|
|
detection of light stimulus involved in sensory perception
|
GO:0050962 |
9 |
0.050
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.049
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.049
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.049
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.049
|
|
|
centrosome organization
|
GO:0051297 |
58 |
0.049
|
|
|
circadian sleep wake cycle process
|
GO:0022410 |
2 |
0.049
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.048
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.048
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.048
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.047
|
|
|
ovulation cycle
|
GO:0042698 |
9 |
0.047
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.047
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.047
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.047
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.046
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.046
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.046
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.046
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.046
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.046
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.045
|
Rat |
|
cellular component disassembly
|
GO:0022411 |
92 |
0.045
|
|
|
protein processing
|
GO:0016485 |
226 |
0.045
|
|
|
response to testosterone
|
GO:0033574 |
1 |
0.045
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.045
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.045
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.044
|
Rat |
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.044
|
|
|
protein targeting to membrane
|
GO:0006612 |
42 |
0.044
|
|
|
response to temperature stimulus
|
GO:0009266 |
22 |
0.044
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.043
|
|
|
fibril organization
|
GO:0097435 |
10 |
0.043
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.043
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.043
|
|
|
cotranslational protein targeting to membrane
|
GO:0006613 |
2 |
0.043
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.043
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.043
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.043
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.042
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.042
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.042
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.041
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.041
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.041
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.041
|
|
|
response to water
|
GO:0009415 |
2 |
0.040
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.040
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.040
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.040
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.040
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.040
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.040
|
|
|
detection of light stimulus involved in visual perception
|
GO:0050908 |
9 |
0.040
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.040
|
Rat |
|
myosin filament organization
|
GO:0031033 |
2 |
0.040
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.039
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.039
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.039
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.038
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.038
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.037
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.037
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.037
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.036
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
37 |
0.036
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.036
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.036
|
|
|
ovulation cycle process
|
GO:0022602 |
9 |
0.036
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.036
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.036
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.036
|
Rat |
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.036
|
|
|
immune response
|
GO:0006955 |
307 |
0.036
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.035
|
|
|
regulation of cell shape
|
GO:0008360 |
48 |
0.035
|
|
|
regulation of retinoic acid receptor signaling pathway
|
GO:0048385 |
9 |
0.035
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.035
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.035
|
|
|
nerve development
|
GO:0021675 |
4 |
0.035
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.035
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.035
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.035
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.034
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.034
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
20 |
0.034
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.034
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.034
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.034
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.034
|
|
|
cell division
|
GO:0051301 |
168 |
0.034
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.033
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
22 |
0.033
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.033
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.033
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.033
|
|
|
vasodilation
|
GO:0042311 |
4 |
0.033
|
|
|
biological phase
|
GO:0044848 |
5 |
0.033
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.033
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.033
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.033
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.033
|
Rat |
|
gonad development
|
GO:0008406 |
34 |
0.033
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.033
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.032
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.032
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.031
|
|
|
signal release
|
GO:0023061 |
70 |
0.031
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.031
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.031
|
|
|
head development
|
GO:0060322 |
108 |
0.031
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.031
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.031
|
|
|
negative regulation of cell division
|
GO:0051782 |
31 |
0.031
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.031
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
3 |
0.031
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.030
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.030
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
27 |
0.030
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.030
|
|
|
behavior
|
GO:0007610 |
112 |
0.030
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.030
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.030
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.030
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.030
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
27 |
0.029
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.029
|
|
|
growth
|
GO:0040007 |
202 |
0.029
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.029
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.029
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.029
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.029
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.029
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.029
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.029
|
|
|
intracellular protein transmembrane transport
|
GO:0065002 |
24 |
0.029
|
|
|
secretion
|
GO:0046903 |
254 |
0.029
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.029
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.029
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
27 |
0.028
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.028
|
|
|
histone modification
|
GO:0016570 |
251 |
0.028
|
Rat |
|
response to axon injury
|
GO:0048678 |
1 |
0.028
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.028
|
|
|
tube development
|
GO:0035295 |
125 |
0.028
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.028
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.028
|
|
|
de novo posttranslational protein folding
|
GO:0051084 |
2 |
0.027
|
|
|
positive regulation of epidermal growth factor receptor signaling pathway
|
GO:0045742 |
11 |
0.027
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.027
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
20 |
0.026
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.026
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.026
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.026
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.026
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.026
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.026
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.026
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.026
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.026
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.026
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.026
|
|
|
positive regulation of dna repair
|
GO:0045739 |
25 |
0.026
|
|
|
protein transmembrane transport
|
GO:0071806 |
25 |
0.025
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.025
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.025
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.025
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.025
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.025
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.025
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.025
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.025
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.025
|
Rat |
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.025
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
23 |
0.024
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.024
|
Rat |
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.024
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.024
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.024
|
|
|
positive regulation of protein targeting to membrane
|
GO:0090314 |
8 |
0.024
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.024
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.024
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.024
|
|
|
circadian sleep wake cycle sleep
|
GO:0050802 |
2 |
0.024
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.024
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.024
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.023
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.023
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.023
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.023
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.023
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.023
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.023
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.023
|
|
|
protein peptidyl prolyl isomerization
|
GO:0000413 |
8 |
0.023
|
|
|
reproduction
|
GO:0000003 |
63 |
0.023
|
|
|
regulation of inclusion body assembly
|
GO:0090083 |
13 |
0.023
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
33 |
0.022
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.022
|
Rat |
|
sensory perception of light stimulus
|
GO:0050953 |
35 |
0.022
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.022
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.022
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.022
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
11 |
0.022
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.022
|
|
|
ovarian follicle development
|
GO:0001541 |
5 |
0.022
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.022
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.022
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.022
|
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.022
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.022
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.022
|
|
|
protein complex disassembly
|
GO:0043241 |
52 |
0.022
|
|
|
response to heat
|
GO:0009408 |
21 |
0.022
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.022
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
13 |
0.021
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.021
|
|
|
response to dexamethasone
|
GO:0071548 |
1 |
0.021
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
22 |
0.021
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.021
|
|